Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Pediatric Chronic Pain
NCT02983682Phase 3Completed
- Sponsor
- SickKids
- Start
- Jan 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic pain, sponsored by SickKids. Primary endpoint: Pain Score. Started Jan 2017; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT02983682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983682.